2:07 PM
 | 
Jan 09, 2018
 |  BC Innovations  |  Distillery Techniques

Biomarker

TECHNOLOGY: Gene profiling; tissue markers

DNA methylation profiling of blood, bone marrow or spleen cells could help predict disease outcomes in juvenile myelomonocytic leukemia (JMML). In peripheral blood or bone marrow mononuclear cell samples from 167 JMML patients, high levels of genomic...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >